Due to network maintenance at the University of Basel, the SWISS-MODEL website will be interrupted this weekend between 07:00 CET Saturday 17th May and 23:55 CET Sunday 18th May.

Multiple Assemblies exist for SMTL entry 6fet
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1439; X-RAY DIFFRACTION 1.88 Å

SMTL ID
6fet.1
Ligands
ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; 1-(2-{4-[(4aS,8aR)-4-[3,4-bis(difluoromethoxy)phenyl]-1-oxo-1,2,4a,5,8,8a-hexahydrophthalazin-2-yl]piperidin-1-yl}-2-oxoethyl)-4,4-dimethylpiperidine-2,6-dione; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; NICKEL (II) ION
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6fet.2
Ligands
ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; DI(HYDROXYETHYL)ETHER; 1-(2-{4-[(4aS,8aR)-4-[3,4-bis(difluoromethoxy)phenyl]-1-oxo-1,2,4a,5,8,8a-hexahydrophthalazin-2-yl]piperidin-1-yl}-2-oxoethyl)-4,4-dimethylpiperidine-2,6-dione
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6fet.3
Ligands
1,2-ETHANEDIOL; ZINC ION; MAGNESIUM ION; DI(HYDROXYETHYL)ETHER; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; TETRAETHYLENE GLYCOL; 1-(2-{4-[(4aS,8aR)-4-[3,4-bis(difluoromethoxy)phenyl]-1-oxo-1,2,4a,5,8,8a-hexahydrophthalazin-2-yl]piperidin-1-yl}-2-oxoethyl)-4,4-dimethylpiperidine-2,6-dione
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6fet.4
Ligands
1,2-ETHANEDIOL; TETRAETHYLENE GLYCOL; ZINC ION; MAGNESIUM ION; DI(HYDROXYETHYL)ETHER; 1-(2-{4-[(4aS,8aR)-4-[3,4-bis(difluoromethoxy)phenyl]-1-oxo-1,2,4a,5,8,8a-hexahydrophthalazin-2-yl]piperidin-1-yl}-2-oxoethyl)-4,4-dimethylpiperidine-2,6-dione; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; NICKEL (II) ION
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer